Ticker Report Equities researchers at StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO Get Rating) in a note issued to investors on Monday. The firm set a strong-buy rating on the medical research companys stock. Global Cord Blood Stock Performance Shares of ...\n more…
Zolmax StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO Get Rating) in a research note released on Monday morning. The brokerage issued a strong-buy rating on the medical research companys stock. Global Cord Blood Price Performance Shares of CO stock opened at $2.99 on ...\n more…
Zolmax Equities research analysts at StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO Get Rating) in a research note issued to investors on Sunday. The firm set a strong-buy rating on the medical research companys stock. Global Cord Blood Trading Up 34.7 % Shares of NYSE CO opened at...\n more…
Ticker Report StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO Get Rating) in a report released on Sunday. The firm issued a strong-buy rating on the medical research companys stock. Global Cord Blood Stock Up 34.7 % NYSE:CO opened at $2.99 on Friday. The stock has a 50 day ...\n more…
Zolmax StockNews.com began coverage on shares of Global Cord Blood (NYSE:CO Get Rating) in a report issued on Saturday morning. The firm issued a strong-buy rating on the medical research companys stock. Global Cord Blood Stock Performance Shares of NYSE:CO opened at $2.99 on Friday. The businesss fifty ...\n more…
Ticker Report Analysts at StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO Get Rating) in a research report issued on Saturday. The firm set a strong-buy rating on the medical research companys stock. Global Cord Blood Stock Up 34.7 % NYSE:CO opened at $2.99 on...\n more…